Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain

Conclusions The time course of a single 30- µg dose was consistent with onset of analgesia and redosing frequency observed in clinical trials. Sublingual sufentanil tablets provide the opportunity to noninvasively and rapidly treat moderate-to-severe pain in a monitored setting.
Source: Anesthesiology - Category: Anesthesiology Source Type: research